Literature DB >> 10439057

von Willebrand factor: from cell biology to the clinical management of von Willebrand's disease.

U M Vischer1, P de Moerloose.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10439057     DOI： 10.1016/s1040-8428(98)00045-6

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN： 1040-8428            Impact factor:   6.312


× No keyword cloud information.
  8 in total

1.  Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP.

Authors:  J E Kaufmann; A Oksche; C B Wollheim; G Günther; W Rosenthal; U M Vischer
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

2.  Virulence factors among Staphylococcus lugdunensis are associated with infection sites and clonal spread.

Authors:  N Giormezis; F Kolonitsiou; A Makri; A Vogiatzi; M Christofidou; E D Anastassiou; I Spiliopoulou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-12-04       Impact factor: 3.267

3.  Von Willebrand factor and oxidative stress parameters in acute coronary syndromes.

Authors:  Zoran Koprivica; Dusica Djordjevic; Milena Vuletic; Vladimir Zivkovic; Nevena Barudzic; Nebojsa Andjelkovic; Dragan Djuric; Violeta Iric-Cupic; Jelena Krkeljic; Vladimir Jakovljevic
Journal:  Oxid Med Cell Longev       Date:  2011-08-08       Impact factor: 6.543

4.  Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma).

Authors:  A Scheja; A Akesson; P Geborek; M Wildt; C B Wollheim; F A Wollheim; U M Vischer
Journal:  Arthritis Res       Date:  2001-02-19

Review 5.  Histamine: an undercover agent in multiple rare diseases?

Authors:  Almudena Pino-Ángeles; Armando Reyes-Palomares; Esther Melgarejo; Francisca Sánchez-Jiménez
Journal:  J Cell Mol Med       Date:  2012-09       Impact factor: 5.310

6.  von Willebrand factor contributes to poor outcome in a mouse model of intracerebral haemorrhage.

Authors:  Ximin Zhu; Yongliang Cao; Lixiang Wei; Ping Cai; Haochen Xu; Haiyu Luo; Xiaofei Bai; Lu Lu; Jian-Ren Liu; Wenying Fan; Bing-Qiao Zhao
Journal:  Sci Rep       Date:  2016-10-26       Impact factor: 4.379

7.  Distinct inflammatory mediator patterns characterize infectious and sterile systemic inflammation in febrile neutropenic hematology patients.

Authors:  Christine Wennerås; Lars Hagberg; Rune Andersson; Lars Hynsjö; Anders Lindahl; Marcin Okroj; Anna M Blom; Peter Johansson; Björn Andreasson; Johan Gottfries; Agnes E Wold
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

8.  Pharmacokinetics, efficacy, and safety of a plasma-derived VWF/FVIII concentrate (VONCENTO) for on-demand and prophylactic treatment in patients with von Willebrand disease (SWIFT-VWD study).

Authors:  Toshko J Lissitchkov; Evgeny Buevich; Kazimierz Kuliczkowski; Oleksandra Stasyshyn; Monica Hermida Cerqueira; Anna Klukowska; Christine Joch; Wilfried Seifert
Journal:  Blood Coagul Fibrinolysis       Date:  2017-03       Impact factor: 1.276
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.